Article Details
Retrieved on: 2021-02-05 06:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Liège, Belgium – 5 February 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), an innovative specialty pharmaceutical company focused on ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here